Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus aspirin in small abdominal aortic aneurysm with elevated hs-CRP
ChiCTR2100051990Phase 4Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rivaroxaban, aspirin and pitavastatin in abdominal aortic aneurysm (AAA) (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Laboratory inspection items. Started Oct 2021; status: recruiting.
02
Drugs
rivaroxabanaspirinpitavastatin
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on ChiCTR2100051990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051990.